Who owns CADRENAL THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Cadrenal Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Cadrenal Therapeutics stock

Who bought or sold CADRENAL THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 54k $747k 12% Sep 2025
 View chart
Citadel Advisors 20k $274k 100% Sep 2025
 View chart
LPL Financial 14k $196k 100% Sep 2025
 View chart
Geode Capital Management 13k $175k 0% Sep 2025
 View chart
Jpmorgan Chase & Co 7.5k $103k 7400% Sep 2025
 View chart
BlackRock 3.4k $47k 3% Sep 2025
 View chart
Advisor Group Holdings 500.00 $6.5k 0% Sep 2025
 View chart
Morgan Stanley 430.00 $5.2k 100% Jun 2025
 View chart
Rockefeller Capital Management 300.00 $4.1k 100% Sep 2025
 View chart
Jones Financial Companies, L.L 172.00 $2.4k 0% Sep 2025
 View chart
Hartland & Co 150.00 $2.1k 100% Sep 2025
 View chart
Harbour Investments 100.00 $1.4k 0% Sep 2025
 View chart
Wells Fargo & Company 99.00 $1.4k -1% Sep 2025
 View chart
UBS Group 35.00 $484.165500 -89% Sep 2025
 View chart
Archer Investment Corp 35.00 $484.001000 0% Sep 2025
 View chart
IFP Advisors 30.00 $414.999000 0% Sep 2025
 View chart

Who sold out of Cadrenal Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Raymond James Financial Jun 2025 1.9k $23k
Tower Research Capital Jun 2025 136.00 $1.6k